Altamira Therapeutics annual revenue
2020
2021
2022
2023
Altamira Therapeutics Revenue Growth & History (CYTOF)
Altamira Therapeutics reported CHF379 in revenue for fiscal 2023, a decrease of 99.88% from the previous fiscal year.
View full Altamira Therapeutics company overviewAltamira Therapeutics annual revenue and growth
| Fiscal year | Period ended | Revenue | Change | Growth |
|---|---|---|---|---|
| 2023 | 2023-12-31 | CHF379 | −CHF305,237 | −99.88% |
| 2022 | 2022-12-31 | CHF305,616 | CHF241,734 | +378.41% |
| 2021 | 2021-12-31 | CHF63,882 | −CHF110,593 | −63.39% |
| 2020 | 2020-12-31 | CHF174,475 | — | — |
About the data
What revenue means
Revenue is the top-line amount a company reports from selling goods and services before expenses are deducted. Fiscal periods can differ from calendar years, so each table includes the exact period end date.
Primary source
SEC company filings
TickerStat standardizes reported company facts from SEC EDGAR. Derived growth rates use the displayed revenue values and are not company guidance or forecasts.
Review Altamira Therapeutics filings at SEC.gov ↗